Drug Trial Radar · NCT05216224
ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Last checked: Nov 20, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
95
Actual
Start
Dec 29, 2021
Primary completion
Dec 23, 2022
Study completion Jan 24, 2023
Sponsor
- Lead sponsor
- Aclaris Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2a study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of ATI-450 vs placebo in patients with moderate to severe Hidradenitis Suppurativa (HS).
Conditions
- Hidradenitis Suppurativa
Interventions
ATI-450Drug
Oral, small molecule MK2 inhibitor
Placebo oral tabletDrug
Placebo tablet manufactured to match ATI-450 in appearance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Abscess and Inflammatory Nodule (AN) Count at Week 12Time frame: Baseline, Week 12
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Aclaris Investigational Site
Birmingham, Alabama
Aclaris Investigational Site
Fort Smith, Arkansas
Aclaris Investigational Site
Encino, California
Aclaris Investigational Site
San Francisco, California
Aclaris Investigational Site
Thousand Oaks, California
Aclaris Investigational Site
Boca Raton, Florida
Aclaris Investigational Site
Hollywood, Florida
Aclaris Investigational Site
Tampa, Florida
Aclaris Investigational Site
Marietta, Georgia
Aclaris Investigational Site
Sandy Springs, Georgia
Aclaris Investigational Site
Metairie, Louisiana
Aclaris Investigational Site
Fort Gratiot, Michigan
Aclaris Investigational Site
Charlotte, North Carolina
Aclaris Investigational Site
Athens, Ohio
Aclaris Investigational Site
Mason, Ohio
Aclaris Investigational Site
Hershey, Pennsylvania
Aclaris Investigational Site
Anderson, South Carolina
Aclaris Investigational Site
Nashville, Tennessee
Aclaris Investigational Site
Houston, Texas
Aclaris Investigational Site
Sugar Land, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.